在癌症治疗中使用活生物疗法
Rasmita Mishra1, Sreelakshmi S Kumar1, T Sayamsmruti Panda1
1Epigenetic and Microbiome Unit, Institute of Life Sciences, Bhubaneswar, Odisha, India.
Progress in molecular biology and translational science
|February 19, 2026
概括
使用微生物的活生物疗法,通过抑制瘤和增强传统疗法,为癌症治疗提供了一种新的方法. 这些微生物剂在减少副作用和克服耐药性方面显示出有前途,以改善癌症管理.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 合成生物学 合成生物学
- 在瘤学瘤学.
背景情况:
- 癌症在诊断和治疗方面提出了全球性的挑战,耐药性和副作用仍然是严重的问题.
- 肠和组织失调与各种癌症有关,包括结肠,胃,胰腺和肝脏的癌症.
- 活生物疗法 (LBPs) 是作为治疗剂来调节癌症病理生理学的微生物.
研究的目的:
- 探索活生物疗法 (LBPs) 作为癌症治疗的新策略的潜力.
- 研究LBP如何抑制瘤生长,增强现有疗法,减轻治疗副作用.
- 突出微生物平衡和直接微生物抗癌作用在癌症管理中的作用.
主要方法:
- 利用本地和人工微生物 (细菌和病毒) 作为治疗剂.
- 使用LBP提供抗瘤有效载荷,包括免疫调节剂和毒素.
- 利用合成生物学和奥米克学的进步,在LBP开发中采用精密方法.
主要成果:
- LBPs在抑制瘤生长和增强化学疗法,放射疗法和免疫疗法等传统癌症疗法方面表现出潜力.
- 微生物干预可以减少与治疗相关的副作用,并克服耐药性.
- 工程化LBP可以通过提供特定的抗瘤有效载荷来设计以向癌细胞.
结论:
- 活生物疗法是一种有希望的下一代癌症治疗策略,结合了微生物学,免疫学和合成生物学.
- LBPs提供优势,如降低全身毒性和与标准治疗的协同效应.
- 尽管面临挑战,合成生物学和个性化方法的创新突显了LBP在瘤学的未来潜力.
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K


